Please use this identifier to cite or link to this item: https://doi.org/10.3390/molecules26195905
DC FieldValue
dc.titleControlled drug delivery systems: Current status and future directions
dc.contributor.authorAdepu, Shivakalyani
dc.contributor.authorRamakrishna, Seeram
dc.date.accessioned2022-10-12T08:01:24Z
dc.date.available2022-10-12T08:01:24Z
dc.date.issued2021-09-29
dc.identifier.citationAdepu, Shivakalyani, Ramakrishna, Seeram (2021-09-29). Controlled drug delivery systems: Current status and future directions. Molecules 26 (19) : 5905. ScholarBank@NUS Repository. https://doi.org/10.3390/molecules26195905
dc.identifier.issn1420-3049
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/232393
dc.description.abstractThe drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to achieve sustained release. Without an efficient delivery mechanism, the whole therapeutic process can be rendered useless. Moreover, the drug has to be delivered at a specified controlled rate and at the target site as precisely as possible to achieve maximum efficacy and safety. Controlled drug delivery systems are developed to combat the problems associated with conventional drug delivery. There has been a tremendous evolution in controlled drug delivery systems from the past two decades ranging from macro scale and nano scale to intelligent targeted delivery. The initial part of this review provides a basic understanding of drug delivery systems with an emphasis on the pharmacokinetics of the drug. It also discusses the conventional drug delivery systems and their limitations. Further, controlled drug delivery systems are discussed in detail with the design considerations, classifications and drawings. In addition, nano-drug delivery, targeted and smart drug delivery using stimuli-responsive and intelligent biomaterials is discussed with recent key findings. The paper concludes with the challenges faced and future directions in controlled drug delivery. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
dc.publisherMDPI
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2021
dc.subjectControlled release dosage forms
dc.subjectIntelligent biomaterials
dc.subjectNano-drug delivery
dc.subjectPharmacokinetics
dc.subjectSmart and stimuli-responsive delivery
dc.typeReview
dc.contributor.departmentCOLLEGE OF DESIGN AND ENGINEERING
dc.description.doi10.3390/molecules26195905
dc.description.sourcetitleMolecules
dc.description.volume26
dc.description.issue19
dc.description.page5905
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3390_molecules26195905.pdf14.61 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons